|Sat April 17, 2004 07:48 AM ET
By Susan Heavey
WASHINGTON (Reuters) - Patients with depression and diabetes may soon join those getting pain relief, birth control hormones and help quitting smoking through skin patches that can deliver medication for days at a time.
Advances in technology, the advantages of continuous drug delivery and rising patient acceptance are helping drive the growth of patches.
Drug makers may also be able to extend patent protection by delivering an existing drug through the skin. "It gives them a little bit more opportunity to profit from that drug," said George Perros, an analyst at Greystone Associates.
Prescription patches were a $5 billion to $8 billion global business in 2003 -- coming a long way since the U.S. Food and Drug Administration first approved a motion sickness patch in 1979.
The top-selling patch is Duragesic, by Johnson & Johnson, a narcotic with $1.63 billion in global sales last year.
Other top sellers include Novartis' Nitroderm for the heart pain of angina, and a number of hormone replacement patches by Novartis and Aventis, according to Kalorama Information, a market research company.
The FDA recently gave conditional approval to a depression-treating patch, expected to launch later this year.
The EmSam patch, by Mylan Laboratories Inc. unit Somerset Pharmaceuticals Inc. and Watson Pharmaceuticals Inc., is the first patch in the huge antidepressant market.
SpectRx Inc. is launching a patch this summer that uses tiny needles to deliver insulin from an attached pump, company spokesman Bill Wells said. SpectRx is also developing a pumpless patch, he said.
Developing patches for insulin and other large molecules is difficult. "The skin is a very tough barrier to get through," said Diane Burgess, a pharmaceutics professor at the University of Connecticut.
Researchers are working on a variety of technologies, including ultrasound and electrical charges, to force bigger molecules through the skin. These so-called "active patches" could pave the way for delivering insulin, as well as red-cell stimulating erythropoietin, to diabetics and anemia patients without injections.
"The next frontier for transdermal delivery is going to be ways to get more active substances and larger molecules ... through the skin," said Greystone's Perros.
Other companies, like Noven, Alza Corporation and Altea Therapeutics, are also working on making patches thinner, smaller and able to carry larger doses.
For patients with chronic conditions, patches can replace the need to take pills every day by providing a steady release of medication for longer periods of time.
"You don't have to remember if you took your pill. You can always see your patch," said Noven CEO Robert Strauss. Noven, in a joint venture with Novartis, makes an estrogen patch the size of a quarter, called Vivelle-Dot.
Skeptics warn that the convenience could make it easy to forget to replace a patch, and skin irritation may force some patients to rotate the patch to different parts of the body.
Some experts say patches are useful only in niche markets and will never surpass pills. "The public really prefers to take an oral tablet. That's the easiest thing to do," said Burgess.
Perros expects demand for medicated patches to grow worldwide by about 11 percent annually through 2007. Kalorama Information estimates 7 percent to 9 percent growth.
"There's going to be a lot more self-medication (and) self-administration of drugs in the future, especially with chronic conditions," said Perros. "You need a way for people to do that ... safely, conveniently and pretty much on a schedule."
|This service is not intended to encourage spam. The details provided by your colleague have been used for the sole purpose of facilitating this email communication and have not been retained by Reuters. Your personal details have not been added to any database or mailing list.
If you would like to receive news articles delivered to your email address, please subscribe at www.reuters.com.
|© Copyright Reuters 2004. All rights reserved. Any copying, re-publication or re-distribution of Reuters content or of any content used on this site, including by framing or similar means, is expressly prohibited without prior written consent of Reuters.|
IN THE WORKPLACE
New Research on Depression in the Workplace.
For more information please click here
To subscribe to SADAG's newsletter, click here
Mental Health Matters Journal for Psychiatrists & GP's
Click here for more info on articles & how to subscribe
Literacy is a luxury that many of us take for granted. We depend on written communication for information, guidance, and access to heath care information That is why SADAG created SPEAKING BOOKS and revolutionized the way information is delivered to low literacy communities. It's exactly what it sounds like.a book that talks to the reader in his or her local language, delivering critical information in an interactive, and educational way.
The customizable 16-page book, accompanied by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood..
We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 30 titles, such as TB, Malaria, Polio, Vaccines for over 30 countries.
- Click here to see speaking books in action
- Click here for sample book on clinical trials
- Click here for latest press release 1.
- Click here for latest press release 2.
- Click here to connect to international site www.booksofhope.com
- Speaking books for Health Care YouTube
Depressed? Diabetic? Drug Patches Moving Past Pain
Dr Reddy's Help Line
0800 21 22 23
Pharmadynamics Police &Trauma Line
0800 20 50 26
Adcock Ingram Depression and Anxiety Helpline
0800 70 80 90
Destiny Helpline for Youth & Students
0800 41 42 43
0800 55 44 33
Department of Social Development Substance Abuse Line 24hr helpline
0800 12 13 14
Suicide Crisis Line
0800 567 567
SADAG Mental Health Line
011 234 4837
Akeso Psychiatric Response Unit 24 Hour
0861 435 787
MENTAL HEALTH CALENDAR 2018
Teen Suicide Prevention Week
11 - 18 February
Bipolar Awareness Day
Substance Abuse Awareness Day
Mental Health Awareness Month
1 – 31 July
Panic Awareness Day
World Suicide Prevention Day
World Mental Health Day
View our list of informative Infographs.
SADAG KZN Branch
SADAG have launched a new office in Durban with the support of Psychiatrist Dr Suvira Ramlall and Clinical Psychologist, Suntosh Pillay.
The offices are placed in St Joseph’s Hospital and are managed by Lyn Norton.
The KZN Branch is deeply committed to;
- Launching new Support Groups
- Workshops on aspects of Mental Health
- School Talks on Suicide Prevention
- Corporate Wellness For KZN companies
Please click here for more information about the KZN activities.
Want to become a volunteer counsellor? Contact Michelle/Christine 0800 21 22 23
Download Application Form Here
If you are interested in starting a Support Group, please contact Michelle on 0800 21 22 23.
To find a Support Group in your area, please phone SADAG on 0800 21 22 23.
If you are a journalist writing a story contact Cassey on
011 234 4837 /firstname.lastname@example.org